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Abstract 
Bcl2-associated athanogene 3 (BAG3) protein is a 
member of BAG family of co-chaperones that 
interacts with the ATPase domain of the heat shock 
protein (Hsp) 70 through BAG domain. BAG3 is 
induced by stressful stimuli, mainly through the 
activity of heat shock factor 1 on bag3 gene 
promoter.  
In addition to the BAG domain, BAG3 contains 
also a WW domain and a proline-rich (PXXP) 
repeat, that mediate binding to partners different 
from Hsp70.  
These multifaceted interactions underlie BAG3 
ability to modulate major biological processes, that 
is, apoptosis, development, cytoskeleton 
organization and autophagy, thereby mediating cell 
adaptive responses to stressful stimuli. In normal 
cells, BAG3 is constitutively present in a very few 
cell types, including cardiomyocytes and skeletal 
muscle cells, in which the protein appears to 
contribute to cell resistance to mechanical stress. 
BAG3 is expressed also in several tumor types 
where it sustains cell survival, resistance to therapy, 
and/or motility and metastatization (Rosati et al., 
2011). 
Identity 
Other names: BAG-3, BIS, CAIR-1, MFM6 
HGNC (Hugo): BAG3 
Location: 10q26.11 
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Green: gene; blue: transcript mRNA; red: coding sequence; black: exons. 
 
DNA/RNA 
Description 
The gene encompasses 33450 bases, 4 exons. 
Transcription 
2608 nucleotides mRNA. 
Pseudogene 
Chromosome 10: 121442639-121443335 reverse 
strand. Name: RP11-179H18.7-001; transcript: 
ENST00000441872. 
Chromosome 10: 121435973-121436791 forward 
strand. Name: PGOHUM00000238940; parent 
protein: ENSP00000358081; parent gene: 
ENSG00000151929. 
Variant: OTTHUMT00000050663. Exons: 5. 
Transcript length: 1146 bps. Translation length: 325 
residues. 
Protein 
Description 
575 amino acids. 74 kDa protein, belonging to the  
evolutionary conserved family of BAG domain-
containing proteins. 
Expression 
Under physiological conditions, BAG3 expression 
appears to be restricted to few cell types including 
skeletal muscle cells and cardiomyocytes (Hishiya 
et al., 2010; De Marco et al., 2011; De Marco et al., 
2013).  
Its expression, however, can be induced in different 
normal cell types (leukocytes, epithelial, glial and 
retinal cells) by a variety of stressors, such as 
oxidants, high temperature, serum deprivation, and 
it is thought to contribute to stress resistance 
(Rosati et al., 2007; Pagliuca et al., 2003; Rosati et 
al., 2009; Ammirante et al., 2010). In contrast to 
normal cells, BAG3 expression is abundant in 
several primary tumors or tumor cell lines, where it 
is thought to give a survival advantage (Rosati et 
al., 2011). Among those melanoma cells, pancreatic 
adenocarcinoma cells, colon cancer, liver cancer, T-
lynph Jurkat cancer, leukemias, kidney HEK-293, 
Lung A549, prostate cancer LnCap, cervix cancer 
Hela, bone cancer U20S, breast cancer cells MCF7. 
 
BAG3 (Bcl-2 associated athanogene 3) d'Avenia M, et al. 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2014; 18(10) 706 
Localisation 
BAG3 is mainly a cytoplasmatic protein, 
particularly concentrated in the rough endoplasmic 
reticulum; a slightly different molecular weight, a 
doublet form or a nuclear localisation can be 
observed in some cell types and/or following cell 
exposure to stressors. BAG3 protein is also released 
from stressed cardiomyocytes and Pancreatic 
Adeno Carcinoma cells (PDAC) and can be 
detected in sera of patients with chronic heart 
failure (HF) or PDAC (De Marco et al., 2013; Falco 
et al., 2013), as well as in cells surnatants. 
Function 
Through its BAG domain, BAG3 protein binds with 
high affinity to the ATPase domain of Hsc70 and 
regulates its chaperone activity in a Hip-modulated 
manner; through its PXXP region, BAG3 binds to 
the SH3 domain of PLC-gamma and forms an 
epidermal growth factor (EGF)-regulated ternary 
complex; the proline-rich repeat appears to be 
involved in regulating cell adhesion and migration, 
through an indirect effect on focal adhesion kinase 
(FAK) and its downstream partners; BAG3 
knockout mice develop a fulminant myopathy; 
downmodulation of BAG3 protein levels enhance 
cell apoptotic response to several inducers, while 
hyperexpression protects cells from apoptosis. 
BAG3 levels increase during myoblast 
differentiation, suggesting that its biological role is 
relevant for differentiated myocytes and not for 
immature cells. This is in agreement with the 
observation that BAG3 deletion causes a lethal 
cardiomyopathy not in embryos, but in postnatal 
mice. BAG3 mutations may cause abnormal Z-disc 
assembly and sensitization to apoptosis in cultured 
cardiomyocytes. More recently it has been shown 
that BAG3 is essential for homeostasis of 
mechanically stressed cells. BAG3 is in fact an 
important component of the chaperone-assisted 
autophagy (CASA) pathway leading to selective 
lysosomal degradation of unfolded proteins. In 
muscle cells the CASA machinery is located at the 
Z-disk and appears to be essential for disposal of 
unfolded mechano-sensors and cytoskeleton 
proteins resulting from mechanical tension. 
Impairment of the CASA machinery results in z-
disk disruption in contracting muscles (Ulbricht et 
al., 2013; Ulbricht and Höhfeld, 2013). 
Homology 
Other members of BAG family. 
Mutations 
Note 
Several reports associate BAG3 mutations with 
myopathy. A mutated form of BAG3, i.e. 
heterozygous Pro209Leu, causes childhood 
cardiomyopathy and a severe and progressive 
muscle weakess (Selcen et al., 2009). Non-
synonymous BAG3 SNPs or others truncated 
BAG3 forms were reported to correlate with 
familiar dilated cardiomyopathy (Villard et al., 
2011) and stress-cardiomyopathy also known as 
Takotsubo cardiomyopathy (Citro et al., 2013). 
Finally, two heterozygous BAG3 gene mutations, 
which cause abnormal Z-disc assembly and 
increased sensitivity to apoptosis in cultured 
cardiomyocytes, were identified in patients with 
familial DCM (Arimura et al., 2011). 
Implicated in 
B-chronic lymphocytic leukaemia 
Disease 
Expression of BAG3 gene in leukaemic cell 
samples from a study on 24 B-CLL-affected 
patients was detected by RT-PCR and 
immunofluorescence. Downmodulation of its levels 
by antisense ODNs resulted in enhancing 
cytochrome c release, caspase 3 activation and 
appearance of hypodiploid elements in response to 
fludarabine (Romano et al., 2003). 
Childhood acute lymphoblastic 
leukemia 
Disease 
Expression of BAG3 gene in leukaemic cell 
samples from a study on 11 ALL- affected patients 
was detected by immunofluorescence. 
Downmodulation of its levels by antisense ODNs 
resulted in stimulating caspase 3 activity and 
enhancing by more than 100% the percentages of 
apoptotic elements in primary cultures, either 
untreated or incubated with cytosine arabinoside 
(Romano et al., 2003). 
Thyroid carcinomas 
Disease 
BAG3 was expressed in human thyroid carcinoma 
cell lines; small interfering RNA-mediated 
downmodulation of its levels significantly 
enhanced NPA cell apoptotic response to TRAIL. 
The protein was not detectable in 19 of 20 
specimens of normal thyroid or goiters, whereas 54 
of 56 analyzed carcinomas (15 follicular 
carcinomas, 28 papillary carcinomas, and 13 
anaplastic carcinomas) were clearly positive for 
BAG3 expression (Li et al., 2013). 
Pancreatic adenocarcinomas 
Disease 
BAG3 protein is expressed in PDACs, but is not 
expressed in the surrounding nonneoplastic tissue. 
Survival is significantly shorter in patients with 
high BAG3 expression than in those with low 
BAG3 expression. Furthermore, BAG3 expression 
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in PDAC-derived cell lines protects from apoptosis 
and confers resistance to gemcitabine, offering a 
partial explanation for the survival data. Indeed 
BAG3 has a relevant role in PDAC biology, and 
BAG3 expression level might be a potential marker 
for prediction of patient outcome (Falco et al., 
2013; Rosati et al., 2012). 
Colorectal carcinomas 
Disease 
Bag3 is distinctly expressed in Colo201, Colo205, 
DLD-1, HCT-15, HCT-116, HT-29, KM-12, 
SW480, SW620, and WiDr at both mRNA and 
protein levels.  
Carcinoma shows stronger Bag-3 expression than 
adjacent NNM by IHC and Western blot. Metastatic 
carcinoma more frequently expressed Bag-3 mRNA 
in lymph node and liver than in primary carcinoma. 
Immunohistochemically, Bag-3 expression is seen 
to gradually decrease from carcinoma, adenoma to 
NNM.  
There is a positive correlation between Bag-3 
expression and TNM staging and GRP94 
expression, but no relationship to patient age or sex, 
tumor size, depth of invasion, lymphatic or venous 
invasion, lymph node metastasis, differentiation or 
prognosis of colorectal carcinomas. Aberrant Bag-3 
expression might be involved in colorectal 
adenoma-adenocarcinoma sequence and subsequent 
progression (Yang et al., 2013). 
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